-
861
-
862
The rate of eye comorbidities in patients with cataracts (results of a population study)
Published 2023-08-01“…Babushkin<sup>1</sup> </p> <p> <sup><br> </sup> </p> <p> <sup>1</sup>Ufa Research Institute of Eye Diseases of the Bashkir State Medical University, Ufa, Russian Federation </p> <p> <sup>2</sup>Russian Center for Eye and Plastic Surgery of Eye Diseases of the Bashkir State Medical University, Ufa, Russian Federation </p> <p> <b>Aim: </b>to assess the prevalence and characteristics of various types of cataracts and to analyze most common eye comorbidities from the population study "Ural Eye and Medical Study" (UEMS). </p> <p> <b>Patients and Methods: </b>this population study included 5899 individuals (3400 living in the rural area and 2499 living in the city). …”
Get full text
Article -
863
Резолюция Экспертного совета «Диагностика и лечение больных со сладжем в желчном пузыре»
Published 2018-08-01Get full text
Article -
864
-
865
Impact of garlic polysulfide supplementation on biochemical and hematological parameters in dairy cows
Published 2024-01-01Get full text
Article -
866
Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice
Published 2022-12-01Get full text
Article -
867
-
868
-
869
Additive effect of brimonidine in maximum tolerated medical therapy for primary open-angle glaucoma
Published 2021-09-01“… Luk’yanova<sup>1</sup></b> </p> <p> <b><sup>1</sup>City Clinical Hospital No. 2, Polyclinic № 1, Chelyabinsk, Russian Federation</b> </p> <p> <b><sup>2</sup>South Ural State Medical University, Chelyabinsk, Russian Federation</b> </p> <p> <i><b>Aim</b>: to evaluate additive IOP-lowering effect of brimonidine 0.2% to achieve target IOP via enhancing maximum tolerated medical therapy for primary open-angle glaucoma (POAG).…”
Get full text
Article -
870
-
871
-
872
-
873
-
874
-
875
Diagnosis and Treatment of Patients with Autoimmune Hepatitis (Experts’ Agreement)
Published 2025-02-01Get full text
Article -
876
-
877
-
878
Hantavirus antibody seroprevalence and risk factors among adults in West Kazakhstan, 2023
Published 2025-01-01Get full text
Article -
879
-
880